PGIM India Healthcare Fund Regular Plan - IDCW Payout
PGIM India Asset Management Private Limited
₹11.64 (+0.52%)
NAV as of 9 Oct 2026
Minimum Investment: ₹5,000
Return
18.90% Returns for 1Y
Expense ratio & Others
- Net expense ratio
- 2.37%
- Exit load
- 0%
- Lock-in
- No
- Minimum investment
- ₹5,000
- Category
- Sector - Healthcare
Expense ratio is inclusive of GST. Returns may be taxed based on the fund type and your holding period — please read the scheme-related documents and consult a tax advisor. Figures are historical and do not guarantee future results.
Fund Returns Estimator
One-time investment
₹1,000
6 months
₹1,200
Invested ₹1,000
▲+20.00%1 year
₹1,189
Invested ₹1,000
▲+18.90%
Based on the fund’s historic trailing returns — a planning illustration, not a guarantee of future results.
Invest One-TimePlan it your way
The figures above are fixed to this fund’s past returns over set periods. Use a calculator to set your own amount, tenure and expected rate of return.
Risk level
Riskometer scale
- Low
- Low to Moderate
- Moderate
- Moderate to High
- High
- Very HighThis fund
Riskometer level assigned by the fund house as per SEBI norms. It can change as the scheme’s portfolio changes.
Fund benchmark
| Primary Index Name | BSE Healthcare PR INR |
|---|---|
| Secondary Index Name | BSE Healthcare PR INR |
| Index Name | BSE Healthcare TR INR |
| Weighting | 100% |
Returns
| 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|
| Fund returns (%) | +18.90% | — | — | — |
| Cumulative returns (%) | +18.90% | — | — | — |
Fund Manager
| Manager | Vivek Sharma |
|---|---|
| Role | Manager |
| Manager Tenure | 1.75 yrs |
About Fund
| Date of Incorporation | 6 Dec 2024 |
|---|---|
| Fund House | PGIM India Asset Management Private Limited |
| Custodian | Standard Chartered Bank |
| Registrar / Transfer Agent | PGIM India Asset Management Private Limited |
| Address | Standard Chartered Bank,1095 Avenue of the Americas,New York, NY 10036,USA |
Top Holdings
| Company | Weightage (%) |
|---|---|
| Divi's Laboratories Ltd | 10.85% |
| Sun Pharmaceuticals Industries Ltd | 10.74% |
| Torrent Pharmaceuticals Ltd | 8.86% |
| J.B. Chemicals & Pharmaceuticals Ltd | 6.40% |
| Aster DM Quality Care Ltd Ordinary Shares | 6.21% |
| Max Healthcare Institute Ltd Ordinary Shares | 4.96% |
| Ajanta Pharma Ltd | 4.83% |
| Manipal Health Enterprises Ltd | 4.12% |
| Mankind Pharma Ltd | 4.07% |
| Rubicon Research Ltd | 4.01% |
| Dr Reddy's Laboratories Ltd | 3.94% |
| Dr. Lal PathLabs Ltd | 3.93% |
| Krishna Institute of Medical Sciences Ltd | 3.77% |
| Abbott India Ltd | 3.74% |
| Global Health Ltd | 3.32% |
| Neuland Laboratories Ltd | 3.26% |
| Navin Fluorine International Ltd | 3.06% |
Investment Strategy
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns
Long term capital growth
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. The data shown is for information only and does not constitute investment advice.